Hympavzi

Medicinal product

(Invented) name

Hympavzi

Active substance (s)

Marstacimabas

Strength

150 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX11, marstacimab

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2024-11-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Užpildytame švirkšte yra	1 ml
Marstacimabas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115884	101989	1101989	užpildytas švirkštas	1 ml N1		Receptinis	EU/1/24/1874/001	Nepradėtas tiekti	-	-	No	-	-

Stadijos

Data	Stadija
2024-11-18	Registruotas